Results 201 to 210 of about 5,789,762 (249)

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

A three-level regulatory mechanism of the aldo-keto reductase subfamily AKR12D. [PDF]

open access: yesNat Commun
Xiao Z   +13 more
europepmc   +1 more source

Factors affecting blood sugar changes in diabetic patients using a three-level model in analysis of longitudinal data. [PDF]

open access: yesCaspian J Intern Med
Rohani T   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy